New patent for Novartis drug KISQALI

Copyright ©
DrugPatentWatch. Originally published at
New patent for Novartis drug KISQALI

Annual Drug Patent Expirations for KISQALI
Annual Drug Patent Expirations for KISQALI

Kisqali is a drug marketed by Novartis and is included in two NDAs. It is available from one supplier. There are seven patents protecting this drug.

This drug has one hundred and thirty-six patent family members in fifty countries.

The generic ingredient in KISQALI is letrozole; ribociclib succinate. One supplier is listed for this compound. Additional details are available on the letrozole; ribociclib succinate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright ©
DrugPatentWatch. Originally published at
New patent for Novartis drug KISQALI